Literature DB >> 34236468

Pessaries and rectovaginal fistulae: consequences of delayed clinical follow-up in the Covid-19 pandemic.

Jordan Mendelson1, Bogdan Grigorescu1,2, Catherine Quinn2, George Lazarou3,4.   

Abstract

INTRODUCTION AND HYPOTHESIS: While 2017 guidelines from The American College of Obstetricians & Gynecologists called for pessary replacement every 3 to 4 months, a recent study in Obstetrics and Gynecology suggested that uninterrupted pessary use up to 6 months is not an independent risk factor for development of pessary-related complications.
METHODS: Our recent experience throughout the Covid-19 pandemic highlights the potential ramifications of delayed clinical follow-up.
RESULTS: During the Covid-19 pandemic, 3 of our patients developed rectovaginal fistulae secondary to Gellhorn pessary erosion in the context of delayed clinical follow-up. Our patients had previously attended routine appointments every 3 months without complications until missed appointments secondary to the pandemic led to fistulae formation.
CONCLUSION: We believe that delayed clinical follow-up of pessary management beyond 3 months due to the Covid-19 pandemic may lead to fistula complications in elderly women with Gellhorn pessaries.

Entities:  

Keywords:  Complication; Covid-19; Delay; Fistula; Gellhorn; Pessary

Year:  2021        PMID: 34236468     DOI: 10.1007/s00192-021-04926-4

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  10 in total

1.  Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse.

Authors:  Ruwan J Fernando; Ranee Thakar; Abdul H Sultan; Sheetle M Shah; Peter W Jones
Journal:  Obstet Gynecol       Date:  2006-07       Impact factor: 7.661

2.  Commentary on "Effect of pessary cleaning and optimal time interval for follow-up: a prospective cohort study".

Authors:  Jerome Melon
Journal:  Int Urogynecol J       Date:  2020-01-13       Impact factor: 2.894

3.  Timing of Office-Based Pessary Care: A Randomized Controlled Trial.

Authors:  Katie Propst; Colleen Mellen; David M O'Sullivan; Paul K Tulikangas
Journal:  Obstet Gynecol       Date:  2020-01       Impact factor: 7.661

Review 4.  Pelvic organ prolapse.

Authors:  J Eric Jelovsek; Christopher Maher; Matthew D Barber
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321

5.  Is it safe and effective to maintain the vaginal pessary without removing it for 2 consecutive years?

Authors:  Alessio Miceli; Manuel Fernández-Sánchez; Juan Polo-Padillo; José-Luis Dueñas-Díez
Journal:  Int Urogynecol J       Date:  2020-02-15       Impact factor: 2.894

6.  Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse.

Authors:  Jeffrey L Clemons; Vivian C Aguilar; Tara A Tillinghast; Neil D Jackson; Deborah L Myers
Journal:  Am J Obstet Gynecol       Date:  2004-04       Impact factor: 8.661

Review 7.  Complications of neglected vaginal pessaries: case presentation and literature review.

Authors:  Beatriz E Arias; Beri Ridgeway; Matthew D Barber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-02-27

8.  Reports of Forgone Medical Care Among US Adults During the Initial Phase of the COVID-19 Pandemic.

Authors:  Kelly E Anderson; Emma E McGinty; Rachel Presskreischer; Colleen L Barry
Journal:  JAMA Netw Open       Date:  2021-01-04

Review 9.  RETIRED: Technical update on pessary use.

Authors:  Magali Robert; Jane A Schulz; Marie-Andrée Harvey
Journal:  J Obstet Gynaecol Can       Date:  2013-07

10.  Effect of pessary cleaning and optimal time interval for follow-up: a prospective cohort study.

Authors:  Susanne D Thys; Robert A Hakvoort; Joyce Asseler; Alfredo L Milani; Astrid Vollebregt; Jan Paul Roovers
Journal:  Int Urogynecol J       Date:  2020-01-06       Impact factor: 2.894

  10 in total
  1 in total

1.  The impact on complication rates of delayed routine pessary reviews during the COVID-19 pandemic.

Authors:  Esther R McNeill; James Lucocq; Kirsty Brown; Vanessa Kay
Journal:  Int Urogynecol J       Date:  2022-08-30       Impact factor: 1.932

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.